
Alzheimer’s Tau Protein Study
The next generation of drugs in the battle against Alzheimer’s disease may possibly be tau protein-targeting antibodies. Tau proteins normally contribute to the health of neurons in the brain, but are damaged by Alzheimer’s disease.
Preliminary Qualifications
-
You are 50-90 years old.
-
You have a clinical diagnosis of early-Alzheimer's.
-
Or you have evidence of pathology consistent with Alzheimer's disease.